Dr. Rosen has overseen numerous phase II and III clinical trials, funded both privately and through the NIH. He is a member of the FDA Advisory Panel on Endocrinologic and Metabolic Drugs and a former chairperson of that committee. He was Permanent Chair of the NIH Review Panel for Skeletal Biology and Bone Diseases for 2002-2004, and is currently a member of the NIAMS Scientific Advisory Board. He served as president of the American Society for Bone and Mineral Research in 2002-2003, and was recently honored to present the Louis V. Avioli Memorial Lecture, “Bone Marrow Fat: Neighbor or Nemesis”, at the 30th Annual ASBMR Official Scientific Meeting in Montreal, Canada. Dr. Rosen’s research interests include the genetic regulation of insulin-like growth factor relative to skeletal metabolism, PTH as an anabolic therapy, and the relationship between marrow adipogenesis and osteoblastogenesis.